Drug delivery company developing sustained-release therapeutics
Re-Vana Therapeutics has raised €11M across 1 funding round from 6 investors, most recently a Series A round in Nov 2022. Based in Belfast, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-30 | Series A | €11M |
| Co-Fund NI,ExSight Ventures,QUBIS,Techstart Ventures,TwinFocus Capital Partners,Visionary Ventures |
| View deal → |
